"Cardiovascular Diseases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
Descriptor ID |
D002318
|
MeSH Number(s) |
C14
|
Concept/Terms |
Cardiovascular Diseases- Cardiovascular Diseases
- Cardiovascular Disease
- Disease, Cardiovascular
- Diseases, Cardiovascular
|
Below are MeSH descriptors whose meaning is more general than "Cardiovascular Diseases".
Below are MeSH descriptors whose meaning is more specific than "Cardiovascular Diseases".
This graph shows the total number of publications written about "Cardiovascular Diseases" by people in this website by year, and whether "Cardiovascular Diseases" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 2 | 2 |
1996 | 1 | 1 | 2 |
1997 | 2 | 2 | 4 |
1998 | 2 | 2 | 4 |
1999 | 0 | 5 | 5 |
2000 | 5 | 3 | 8 |
2001 | 5 | 4 | 9 |
2002 | 9 | 6 | 15 |
2003 | 10 | 8 | 18 |
2004 | 14 | 6 | 20 |
2005 | 15 | 7 | 22 |
2006 | 12 | 11 | 23 |
2007 | 15 | 12 | 27 |
2008 | 19 | 11 | 30 |
2009 | 23 | 10 | 33 |
2010 | 24 | 16 | 40 |
2011 | 24 | 11 | 35 |
2012 | 21 | 9 | 30 |
2013 | 27 | 10 | 37 |
2014 | 33 | 7 | 40 |
2015 | 20 | 5 | 25 |
2016 | 27 | 6 | 33 |
2017 | 22 | 5 | 27 |
2018 | 25 | 9 | 34 |
2019 | 29 | 4 | 33 |
2020 | 29 | 6 | 35 |
2021 | 31 | 8 | 39 |
2022 | 29 | 0 | 29 |
2023 | 38 | 1 | 39 |
2024 | 3 | 0 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cardiovascular Diseases" by people in Profiles.
-
A Cross-Sectional Analysis of Cardiovascular and Bone Health Care Utilization During Treatment With Thyroid Hormone. J Clin Endocrinol Metab. 2024 Feb 20; 109(3):e1143-e1150.
-
Age and Aspirin Dosing in Secondary Prevention of Atherosclerotic Cardiovascular Disease. J Am Heart Assoc. 2024 Feb 20; 13(4):e026921.
-
Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease and Diabetes Mellitus: A Subgroup Analysis of the ADAPTABLE Trial. Diabetes Care. 2024 Jan 01; 47(1):81-88.
-
Rest-Activity Rhythms Are Associated With Prevalent Cardiovascular Disease, Hypertension, Obesity, and Central Adiposity in a Nationally Representative Sample of US Adults. J Am Heart Assoc. 2024 Jan 02; 13(1):e032073.
-
Specialty preference for cardiovascular prevention practice in the Southeast US and role of a preventive cardiologist. Postgrad Med J. 2023 Dec 21; 100(1179):42-49.
-
Major Adverse Cardiovascular Events by Baseline Cardiovascular Risk in Patients with Ulcerative Colitis Treated with Tofacitinib: Data from the OCTAVE Clinical Programme. J Crohns Colitis. 2023 Nov 24; 17(11):1761-1770.
-
Red Blood Cell Transfusion: 2023 AABB International Guidelines. JAMA. 2023 11 21; 330(19):1892-1902.
-
Estimated Lifetime Cardiovascular, Kidney, and Mortality Benefits of Combination Treatment With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Nonsteroidal MRA Compared With Conventional Care in Patients With Type 2 Diabetes and Albuminuria. Circulation. 2024 Feb 06; 149(6):450-462.
-
Clinicians' self-reported efficacy in cardiovascular prevention practice in the southeastern United States. Future Cardiol. 2023 09; 19(12):593-604.
-
Effectiveness and Safety of Enteric-Coated vs Uncoated Aspirin in Patients With Cardiovascular Disease: A Secondary Analysis of the ADAPTABLE Randomized Clinical Trial. JAMA Cardiol. 2023 11 01; 8(11):1061-1069.